Winter TA - Search Results

1

Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study.

Winter TA, Wright J, Ghosh S, Jahnsen J, Innes A, Round P. Winter TA, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1337-46. doi: 10.1111/j.1365-2036.2004.02285.x. Aliment Pharmacol Ther. 2004. PMID: 15606396 Free article. Clinical Trial.

2

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E. Thomsen OO, et al. N Engl J Med. 1998 Aug 6;339(6):370-4. doi: 10.1056/NEJM199808063390603. N Engl J Med. 1998. PMID: 9691103 Free article. Clinical Trial.

3

Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.

Wright JP, Winter TA, Candy S, Marks IS. Wright JP, et al. Among authors: winter ta. Dig Dis Sci. 1999 Sep;44(9):1899-901. doi: 10.1023/a:1018863210931. Dig Dis Sci. 1999. PMID: 10505732 Clinical Trial.

4

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.

Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E; International Budesonide-Mesalazine Study Group. Thomsen OO, et al. Am J Gastroenterol. 2002 Mar;97(3):649-53. doi: 10.1111/j.1572-0241.2002.05544.x. Am J Gastroenterol. 2002. PMID: 11922560 Clinical Trial.

5

Treatment of Crohn's disease with certolizumab pegol.

Winter TA, Sandborn WJ, de Villiers WJ, Schreiber S. Winter TA, et al. Expert Rev Clin Immunol. 2007 Sep;3(5):683-94. doi: 10.1586/1744666X.3.5.683. Expert Rev Clin Immunol. 2007. PMID: 20477019

6

CDP870 in Crohn's disease: reconsidering endpoints.

Winter TA, de Villiers WJ, Mardini HE. Winter TA, et al. Inflamm Bowel Dis. 2006 Mar;12(3):249. doi: 10.1097/01.MIB.0000202557.16581.42. Inflamm Bowel Dis. 2006. PMID: 16534429 No abstract available.

7

Omeprazole and ranitidine in duodenal ulcer healing.

Marks IN, Winter TA, Lucke W, Wright JP, Newton KA, O'Keefe SJ, Marotta F. Marks IN, et al. Among authors: winter ta. S Afr Med J. 1988 Jul 2;74 Suppl:54-6. S Afr Med J. 1988. PMID: 3291156 Clinical Trial. No abstract available.

8

Impaired gastric acid and pancreatic enzyme secretion in patients with Crohn's disease may be a consequenece of a poor nutritional state.

Winter TA, O'keefe SJ, Callanan M, Marks T. Winter TA, et al. Inflamm Bowel Dis. 2004 Sep;10(5):618-25. doi: 10.1097/00054725-200409000-00018. Inflamm Bowel Dis. 2004. PMID: 15472524

9

Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

Schreiber S, Feagan B, D'Haens G, Colombel JF, Geboes K, Yurcov M, Isakov V, Golovenko O, Bernstein CN, Ludwig D, Winter T, Meier U, Yong C, Steffgen J; BIRB 796 Study Group. Schreiber S, et al. Clin Gastroenterol Hepatol. 2006 Mar;4(3):325-34. doi: 10.1016/j.cgh.2005.11.013. Clin Gastroenterol Hepatol. 2006. PMID: 16527696 Clinical Trial.

10

Effect of severe undernutrition and subsequent refeeding on gut mucosal protein fractional synthesis in human subjects.

Winter TA, O'Keefe SJ, Callanan M, Marks T. Winter TA, et al. Nutrition. 2007 Jan;23(1):29-35. doi: 10.1016/j.nut.2006.10.005. Nutrition. 2007. PMID: 17189088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page